logo-loader
RNS
AOTI Inc

AOTI, Inc. - Director/PDMR Shareholding - ESPP

RNS Number : 2712P
AOTI, Inc.
04 August 2026
 

4 August 2026 

 

AOTI INC. (the "Company")

 

Directors'/PDMR Shareholding - Employee Share Purchase Plan

 

The Company was informed on 3 August 2026, that the following purchases of AOTI, Inc. common shares were made by CSC Global1 on 3 August 2026 on behalf of certain of the Company's persons discharging managerial responsibilities ("PDMR") pursuant to the Company's Employee Share Purchase Plan ("ESPP").

 

Under the ESPP, participating employees make regular payroll contributions which are used to acquire shares in the Company. Further information regarding the ESPP can be found in the announcement of 1 May 2026.

 

1CSC Global operates through CSC Employee Benefit Trustee (Jersey) Limited and CSC Employee Benefit Services (Jersey) Limited

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Mike Griffiths

Jayesh Pankhania

Anthony Moffatt

2

 

Reason for the notification

 

a)

 

Position/status

 

1.   Chief Executive Officer

2.   Chief Financial Officer

3.   Chief Operating Officer

 

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

AOTI Inc.

b)

 

LEI

 

213800ZGCNDSTWIRK687

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Common shares of $0.00001 each

 

 

ISIN: US03690C1027

b)

 

Nature of the transaction

 

 

Purchase of common shares by the Trustee of the Employee Share Purchase Plan

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Resultant shareholding post purchase

Resultant % of ISC post purchase

1.   £0.975p

2.   £0.975p

3.   £0.975p

 

918

921

927

 

6,788,972

406,460

1,181,827

6.38%

0.38%

1.11%





d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

NA

 

NA

e)

 

Date of the transaction

 

3 August 2026

f)

 

Place of the transaction

 

London Stock Exchange

 

 

 

END

 

AOTI, INC.

Dr. Mike Griffiths, Chief Executive Officer

Jayesh Pankhania, Chief Financial Officer

 

 

+44 (0)20 3727 1000

ir@aotinc.net

Peel Hunt LLP (Nominated Adviser and Joint Broker)

Dr. Christopher Golden, James Steel

 

 

 

+44 (0)20 7418 8900

Panmure Liberum Limited (Joint Broker)

Emma Earl, Will Goode, Mark Rogers

Rupert Dearden

 

+44 (0)20 3100 2000

 

FTI Consulting (Financial PR & IR)

Ben Atwell, Simon Conway,

Natalie Garland-Collins

 

+44 (0)20 3727 1000

AOTI@fticonsulting.com

 

 

ABOUT AOTI, INC.

 

AOTI, INC. was founded in 2006 and is based in Oceanside, California, US and Galway, Ireland, providing innovative solutions to resolve severe and chronic wounds worldwide. Its products reduce healthcare costs and improve the quality of life for patients with these debilitating conditions. The Company's patented non-invasive Topical Wound Oxygen (TWO2®) therapy has demonstrated in differentiating, robust, double-blinded randomized controlled trials (RCT) and real-world evidence (RWE) studies to more-durably reduce the recurrence of Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 per cent reduction in hospitalizations and 71 per cent. reduction in amputations over 12 months. TWO2® therapy can be administered by the patient at home, improving access to care and enhancing treatment compliance. TWO2® therapy has received regulatory clearance from the US (FDA), Europe (CE Mark), UK (MHRA), Health Canada, the Chinese National Medical Products Administration, Australia (TGA) and in Saudi Arabia. TWO2® therapy has also recently received positive coverage recommendations from the Federal Joint Committee (G-BA) in Germany and National Institute for Health and Care Excellence (NICE) in the United Kingdom. Also see www.aotinc.net

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSAFILEMSESA
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

AOTI set for expanded Medicare coverage following positive CMS proposal

AOTI CEO Dr. Mike Griffiths joined Steve Darling from Proactive to discuss a major regulatory milestone after the Centers for Medicare & Medicaid Services (CMS) issued a proposed Local Coverage Determination (LCD) supporting the use of topical oxygen therapy for diabetic foot ulcers that...

on 07/30/2026

3 min read